March Cannabis Sales Looked Decent Nationally. In the West, Four of Five States Shrank Year-Over-Year.

BDSA's March data shows cannabis sales across 15 states totaled $2.14 billion — up 6.5% month-over-month, down 3.8% per-day adjusted. In the West, four of five tracked states shrank year-over-year. Oregon is the standout case study in what happens when a legal market matures faster than it can consolidate.

March Cannabis Sales Looked Decent Nationally. In the West, Four of Five States Shrank Year-Over-Year.
Cannabis product display at a licensed dispensary. Cannabis Tours / Wikimedia Commons (CC BY-SA 4.0)

March Cannabis Sales Looked Decent Nationally. In the West, Four of Five States Shrank Year-Over-Year.

The March cannabis sales number that’s getting passed around this week — $2.14 billion across 15 legal markets, up 6.5% from February — sounds like a recovery signal. It isn’t, not really. March has 31 days. February had 28. When you adjust for the extra three days of selling time, national cannabis sales actually fell 3.8% on a per-day basis.

That’s the sleight of hand buried in the headline. And in the western markets, where California, Oregon, Nevada, Arizona, and Colorado make up BDSA’s tracked footprint, there’s no flattering way to read the data at all.

Four of five western states posted negative year-over-year growth in March. Sales fell compared to the same month in 2025 across most of the region’s legal landscape — not just on a per-day basis, but in absolute terms. The West, which built this industry, is watching the rest of the country post stronger relative numbers while its own mature markets grind sideways or down.

The Math Behind the Headline

BDSA tracks retail cannabis sales in 15 states. In March 2026, combined sales across those markets hit $2.14 billion — a 1.6% increase year-over-year and a 6.5% sequential jump from February. Those are the numbers circulating in industry press this week, and they’re technically accurate.

The adjustment that matters more: per-day sales. March has three more selling days than February. On a normalized basis, operators didn’t actually move more product per day in March — they moved less. Sequential growth of 6.5% gross becomes a 3.8% per-day decline. For operators who are managing cash flow week to week, that distinction matters.

For the eastern markets, there are pockets of real growth — Ohio’s adult-use program, which launched in August 2025, is still in its honeymoon phase, posting +32.7% year-over-year. New York and New Jersey have fresh dispensary counts boosting volume. The East has states still in early innings.

The West doesn’t have that cushion. California, Oregon, Nevada, Arizona, and Colorado are all mature markets — some of the oldest adult-use systems in the country. They’re not getting a legalization bump. They’re competing with themselves, with each other, and increasingly with a federal hemp market that’s eating into the lower end of the price spectrum.

California: The Market That Can’t Shake Its Structural Problems

California is the one that sets the tone. It’s the largest legal cannabis market in the country by a wide margin — roughly a third of total U.S. tracked sales flow through the state. When California’s numbers are soft, the national aggregate softens with it.

The state has been navigating a slow-motion contraction that predates the current tariff-and-inflation environment. Excise taxes that remain among the highest in the nation. An illicit market that, by most estimates, still accounts for more than 60% of total cannabis consumption in the state. A licensing system so fragmented that thousands of small operators are competing in markets where they can’t achieve scale. Retail density that’s uneven — urban corridors with competing dispensaries on every block, while large rural counties remain effectively locked out of the legal system.

What March 2026 data reflects in California is what the state has been living with for going on two years: flat-to-down volume, continued price compression, and a shrinking slice of the overall consumption pie relative to the illicit market. The per-day adjustment makes the month look even weaker than the headline suggests.

The only thing propping up the California revenue line in recent quarters has been premium products — high-end solventless concentrates, exotic flower, limited-release collaboration drops. The consumer who’s still buying inside the legal system in California skews toward quality. Volume is going elsewhere.

Oregon: Where “Mature” Became “Distressed”

If California is the slow grind, Oregon is the cautionary tale.

Oregon has been in a state of chronic oversupply since roughly 2019. The state licensed aggressively — too aggressively — in the early years, and the wholesale cannabis price has been in freefall for so long that the current environment feels less like a market and more like an ongoing liquidation. Wholesale flower in Oregon has at various points in recent years traded below $100 a pound. That’s below the cost of production for most operators.

The dispensary count has remained stubbornly high relative to demand. Oregon has more cannabis retailers per capita than nearly any legal market in the country. That sounds like consumer convenience; what it actually means is that every operator is fighting for a smaller piece of the same pie.

BDSA’s March data confirms Oregon is still contracting year-over-year. That’s not a surprise to anyone paying attention to this market. What it is, is a warning to states in earlier stages of legalization that the path from “exciting new market” to “structurally distressed” is shorter than most people expect — especially when the licensing framework doesn’t include built-in consolidation mechanisms.

Oregon did pass HB4162 this session, repealing the worker neutrality requirement from Ballot Measure 119. Whatever your read on the labor policy implications, it signals that Oregon’s cannabis legislature is increasingly focused on operator survival over ideological purity. That’s what a distressed market does to politics.

Nevada and Arizona: Tourism Dependency and Its Limits

Nevada’s cannabis market has always been a somewhat artificial construction — built on Las Vegas tourism dollars rather than residential demand. When the convention calendar fills up, Nevada’s dispensaries do well. When travel softens, the numbers follow.

March 2026 is a complicated month for Nevada to read. Spring break overlap with BDSA’s reporting window may introduce some noise. But the underlying trend — year-over-year decline — is consistent with what’s been happening across the region. Nevada dispensaries in the tourist corridor have been aggressive on price to compete for wallet share against alcohol, shows, and sports betting. Margin compression is severe.

Arizona is a more interesting market. It’s one of the younger adult-use systems in the West, having launched in 2021, and it’s been a relative bright spot in terms of market structure — a handful of large operators with efficient retail footprints, reasonable tax structure, and a consumer base that wasn’t previously well-served by a medical-only system. But even Arizona is now posting negative year-over-year growth. The early-days volume surge is gone. Arizona is entering the same maturation cycle that California and Oregon navigated years earlier.

Colorado, the original. Thirteen years into adult-use legalization, it’s been navigating the same headwinds as California for years. The state’s cannabis market peaked by revenue in 2021 and has been compressing since. The tariff environment affecting vape hardware and packaging isn’t helping — Colorado operators have significant exposure to Chinese-sourced inputs. HB1409, which sets new rules for how the state’s marijuana tax cash fund gets distributed, is working its way through the legislature this week and underscores that Colorado is now in the phase where the policy conversation is about sustainability, not growth.

What This Means for West Coast Operators Right Now

For operators in these markets, the March data confirms what most of them already know: there is no cavalry coming. Federal rescheduling, even if it happens this year, won’t immediately solve pricing pressure or illicit market competition. The national headline number of $2.14 billion sounds like stability. The per-day reality and the western state specifics say something different.

The operators who are going to survive the next 12 to 18 months in the West are the ones who have already made hard choices about footprint, product mix, and overhead. Consolidation is accelerating — not because anyone wants to sell, but because the math is forcing it. The MSO shakeout that’s playing out nationally is mirrored in smaller form in state markets: fewer operators with bigger slices, or everyone staying small and watching margins erode together.

Oregon, California, and Nevada are three different versions of the same problem. They’re legal markets that built infrastructure for a future that hasn’t arrived — one where federal normalization, banking access, and illicit market suppression were supposed to close the competitive gap. That gap hasn’t closed. And the March 2026 data, when you strip out the calendar math, shows exactly where the West stands as a result.

The national number says +6.5%. The per-day number says -3.8%. The western states say four of five are going backward year-over-year.

Pick which one tells you more.

Jo Tanaka covers the West Coast and Pacific markets for CannabisInquirer.com. She is based in Portland.

Sponsored
PuffyParcel
Skip the Dispensary. Lab-Tested THCa Delivered to Your Door.
100% federally legal hemp-derived products from small U.S. growers — discreetly shipped straight to you. Free shipping on orders over $50.
Shop Now →

Responses

💬
Be the first to weigh in.
Perspectives from every state matter here. Where do you stand?

Your email won't be published. Staff occasionally respond.

✓ Response submitted — it'll appear here after a quick review.
Something went wrong. Check your fields and try again.